These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1356 related articles for article (PubMed ID: 15316165)
1. An open, randomized, comparative study of oral finasteride and 5% topical minoxidil in male androgenetic alopecia. Arca E; Açikgöz G; Taştan HB; Köse O; Kurumlu Z Dermatology; 2004; 209(2):117-25. PubMed ID: 15316165 [TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of 3% minoxidil versus combined 3% minoxidil / 0.1% finasteride in male pattern hair loss: a randomized, double-blind, comparative study. Tanglertsampan C J Med Assoc Thai; 2012 Oct; 95(10):1312-6. PubMed ID: 23193746 [TBL] [Abstract][Full Text] [Related]
3. A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss. Lucky AW; Piacquadio DJ; Ditre CM; Dunlap F; Kantor I; Pandya AG; Savin RC; Tharp MD J Am Acad Dermatol; 2004 Apr; 50(4):541-53. PubMed ID: 15034503 [TBL] [Abstract][Full Text] [Related]
7. Controversies in the treatment of androgenetic alopecia: The history of finasteride. Andy G; John M; Mirna S; Rachita D; Michael K; Maja K; Aseem S; Zeljana B Dermatol Ther; 2019 Mar; 32(2):e12647. PubMed ID: 30253001 [TBL] [Abstract][Full Text] [Related]
8. A randomized, single-blind trial of 5% minoxidil foam once daily versus 2% minoxidil solution twice daily in the treatment of androgenetic alopecia in women. Blume-Peytavi U; Hillmann K; Dietz E; Canfield D; Garcia Bartels N J Am Acad Dermatol; 2011 Dec; 65(6):1126-1134.e2. PubMed ID: 21700360 [TBL] [Abstract][Full Text] [Related]
9. [Efficacy and tolerability of 5% minoxidil solution (Carexidil®) in male and female androgenetic alopecia: a 6-month open multicentric study]. Piraccini B; Starace M; Alessandrini A; Guarrera M; Fiorucci MC; Lorenzi S G Ital Dermatol Venereol; 2011 Dec; 146(6 Suppl 1):1-8. PubMed ID: 22189834 [TBL] [Abstract][Full Text] [Related]
10. Combined treatment with oral finasteride and topical minoxidil in male androgenetic alopecia: a randomized and comparative study in Chinese patients. Hu R; Xu F; Sheng Y; Qi S; Han Y; Miao Y; Rui W; Yang Q Dermatol Ther; 2015; 28(5):303-8. PubMed ID: 26031764 [TBL] [Abstract][Full Text] [Related]
11. Comparison of the efficacy and safety of topical minoxidil and topical alfatradiol in the treatment of androgenetic alopecia in women. Blume-Peytavi U; Kunte C; Krisp A; Garcia Bartels N; Ellwanger U; Hoffmann R J Dtsch Dermatol Ges; 2007 May; 5(5):391-5. PubMed ID: 17451383 [TBL] [Abstract][Full Text] [Related]
12. Systemic steroids with or without 2% topical minoxidil in the treatment of alopecia areata. Olsen EA; Carson SC; Turney EA Arch Dermatol; 1992 Nov; 128(11):1467-73. PubMed ID: 1444500 [TBL] [Abstract][Full Text] [Related]
13. Patient-reported outcomes of topical finasteride/minoxidil treatment for male androgenetic alopecia: A retrospective study using telemedical data. Abeck F; Hansen I; Kött J; Schröder F; Garrahy E; Veneroso J; Rünger A; Torster L; Schneider SW; von Büren J J Cosmet Dermatol; 2024 Sep; 23(9):2956-2963. PubMed ID: 38713003 [TBL] [Abstract][Full Text] [Related]
14. A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men. Olsen EA; Whiting D; Bergfeld W; Miller J; Hordinsky M; Wanser R; Zhang P; Kohut B J Am Acad Dermatol; 2007 Nov; 57(5):767-74. PubMed ID: 17761356 [TBL] [Abstract][Full Text] [Related]
15. Topical minoxidil therapy for androgenetic alopecia. A 30-month study. Koperski JA; Orenberg EK; Wilkinson DI Arch Dermatol; 1987 Nov; 123(11):1483-7. PubMed ID: 3314717 [TBL] [Abstract][Full Text] [Related]
16. A randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia. Suchonwanit P; Srisuwanwattana P; Chalermroj N; Khunkhet S J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2257-2263. PubMed ID: 29972712 [TBL] [Abstract][Full Text] [Related]
17. Androgenetic alopecia in the female. Treatment with 2% topical minoxidil solution. DeVillez RL; Jacobs JP; Szpunar CA; Warner ML Arch Dermatol; 1994 Mar; 130(3):303-7. PubMed ID: 8129407 [TBL] [Abstract][Full Text] [Related]
18. Oral Minoxidil vs Topical Minoxidil for Male Androgenetic Alopecia: A Randomized Clinical Trial. Penha MA; Miot HA; Kasprzak M; Müller Ramos P JAMA Dermatol; 2024 Jun; 160(6):600-605. PubMed ID: 38598226 [TBL] [Abstract][Full Text] [Related]
19. A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia. Gubelin Harcha W; Barboza Martínez J; Tsai TF; Katsuoka K; Kawashima M; Tsuboi R; Barnes A; Ferron-Brady G; Chetty D J Am Acad Dermatol; 2014 Mar; 70(3):489-498.e3. PubMed ID: 24411083 [TBL] [Abstract][Full Text] [Related]
20. Is topical minoxidil solution effective on androgenetic alopecia in routine daily practice? Mapar MA; Omidian M J Dermatolog Treat; 2007; 18(5):268-70. PubMed ID: 17917938 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]